AMERICAN SUPERCONDUCTOR CORP (AMSC)

US0301112076 - Common Stock

25.02  -0.29 (-1.15%)

After market: 24.8201 -0.2 (-0.8%)

Fundamental Rating

4

AMSC gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 88 industry peers in the Electrical Equipment industry. AMSC scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. AMSC shows excellent growth, but is valued quite expensive already.



2

1. Profitability

1.1 Basic Checks

In the past year AMSC was profitable.
AMSC had a positive operating cash flow in the past year.
In the past 5 years AMSC always reported negative net income.
AMSC had negative operating cash flow in 4 of the past 5 years.

1.2 Ratios

AMSC's Return On Assets of -0.29% is fine compared to the rest of the industry. AMSC outperforms 68.18% of its industry peers.
With a decent Return On Equity value of -0.46%, AMSC is doing good in the industry, outperforming 68.18% of the companies in the same industry.
Industry RankSector Rank
ROA -0.29%
ROE -0.46%
ROIC N/A
ROA(3y)-11.92%
ROA(5y)-12.59%
ROE(3y)-22.67%
ROE(5y)-22.24%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

AMSC has a better Gross Margin (27.39%) than 65.91% of its industry peers.
AMSC's Gross Margin has been stable in the last couple of years.
The Profit Margin and Operating Margin are not available for AMSC so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 27.39%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y6.44%
GM growth 5Y-0.56%

6

2. Health

2.1 Basic Checks

AMSC does not have a ROIC to compare to the WACC, probably because it is not profitable.
AMSC has more shares outstanding than it did 1 year ago.
AMSC has more shares outstanding than it did 5 years ago.
AMSC has a better debt/assets ratio than last year.

2.2 Solvency

Based on the Altman-Z score of 1.29, we must say that AMSC is in the distress zone and has some risk of bankruptcy.
AMSC's Altman-Z score of 1.29 is in line compared to the rest of the industry. AMSC outperforms 54.55% of its industry peers.
There is no outstanding debt for AMSC. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 1.29
ROIC/WACCN/A
WACC10.18%

2.3 Liquidity

AMSC has a Current Ratio of 2.05. This indicates that AMSC is financially healthy and has no problem in meeting its short term obligations.
AMSC's Current ratio of 2.05 is in line compared to the rest of the industry. AMSC outperforms 54.55% of its industry peers.
AMSC has a Quick Ratio of 1.31. This is a normal value and indicates that AMSC is financially healthy and should not expect problems in meeting its short term obligations.
AMSC has a Quick ratio of 1.31. This is comparable to the rest of the industry: AMSC outperforms 48.86% of its industry peers.
Industry RankSector Rank
Current Ratio 2.05
Quick Ratio 1.31

7

3. Growth

3.1 Past

AMSC shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 168.25%, which is quite impressive.
AMSC shows a strong growth in Revenue. In the last year, the Revenue has grown by 46.94%.
Measured over the past years, AMSC shows a very strong growth in Revenue. The Revenue has been growing by 20.98% on average per year.
EPS 1Y (TTM)168.25%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%244.8%
Revenue 1Y (TTM)46.94%
Revenue growth 3Y18.69%
Revenue growth 5Y20.98%
Sales Q2Q%60.19%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
The Revenue is expected to grow by 25.85% on average over the next years. This is a very strong growth
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year49.67%
Revenue Next 2Y33.19%
Revenue Next 3Y25.85%
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

2

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 58.19, the valuation of AMSC can be described as expensive.
Based on the Price/Earnings ratio, AMSC is valued a bit cheaper than 68.18% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 27.37. AMSC is valued rather expensively when compared to this.
Based on the Price/Forward Earnings ratio of 46.57, the valuation of AMSC can be described as expensive.
67.05% of the companies in the same industry are more expensive than AMSC, based on the Price/Forward Earnings ratio.
AMSC is valuated expensively when we compare the Price/Forward Earnings ratio to 23.85, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 58.19
Fwd PE 46.57

4.2 Price Multiples

AMSC's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. AMSC is cheaper than 68.18% of the companies in the same industry.
Industry RankSector Rank
P/FCF 54.08
EV/EBITDA N/A

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

AMSC does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

AMERICAN SUPERCONDUCTOR CORP

NASDAQ:AMSC (12/24/2024, 3:13:59 PM)

After market: 24.8201 -0.2 (-0.8%)

25.02

-0.29 (-1.15%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryElectrical Equipment
Earnings (Last)10-30 2024-10-30/amc
Earnings (Next)N/A N/A
Inst Owners73.09%
Inst Owner Change0.47%
Ins Owners4.67%
Ins Owner Change7.74%
Market Cap987.04M
Analysts84.44
Price Target30.94 (23.66%)
Short Float %7%
Short Ratio1.78
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)597.61%
Min EPS beat(2)510.91%
Max EPS beat(2)684.31%
EPS beat(4)4
Avg EPS beat(4)435.3%
Min EPS beat(4)151.9%
Max EPS beat(4)684.31%
EPS beat(8)6
Avg EPS beat(8)230.96%
EPS beat(12)7
Avg EPS beat(12)153.72%
EPS beat(16)10
Avg EPS beat(16)116.73%
Revenue beat(2)2
Avg Revenue beat(2)3.02%
Min Revenue beat(2)0.42%
Max Revenue beat(2)5.61%
Revenue beat(4)4
Avg Revenue beat(4)7.62%
Min Revenue beat(4)0.42%
Max Revenue beat(4)13.47%
Revenue beat(8)7
Avg Revenue beat(8)6.85%
Revenue beat(12)9
Avg Revenue beat(12)4.55%
Revenue beat(16)12
Avg Revenue beat(16)4.45%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)81.81%
EPS NY rev (1m)0%
EPS NY rev (3m)76.47%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)42.5%
Revenue NY rev (1m)0%
Revenue NY rev (3m)2.72%
Valuation
Industry RankSector Rank
PE 58.19
Fwd PE 46.57
P/S 5.6
P/FCF 54.08
P/OCF 50.34
P/B 5.28
P/tB 7.55
EV/EBITDA N/A
EPS(TTM)0.43
EY1.72%
EPS(NY)0.54
Fwd EY2.15%
FCF(TTM)0.46
FCFY1.85%
OCF(TTM)0.5
OCFY1.99%
SpS4.46
BVpS4.74
TBVpS3.31
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.29%
ROE -0.46%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 27.39%
FCFM 10.36%
ROA(3y)-11.92%
ROA(5y)-12.59%
ROE(3y)-22.67%
ROE(5y)-22.24%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y6.44%
GM growth 5Y-0.56%
F-Score6
Asset Turnover0.59
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA N/A
Cap/Depr 29.11%
Cap/Sales 0.77%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.05
Quick Ratio 1.31
Altman-Z 1.29
F-Score6
WACC10.18%
ROIC/WACCN/A
Cap/Depr(3y)20.51%
Cap/Depr(5y)40.37%
Cap/Sales(3y)0.89%
Cap/Sales(5y)2.39%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)168.25%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%244.8%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)46.94%
Revenue growth 3Y18.69%
Revenue growth 5Y20.98%
Sales Q2Q%60.19%
Revenue Next Year49.67%
Revenue Next 2Y33.19%
Revenue Next 3Y25.85%
Revenue Next 5YN/A
EBIT growth 1Y66.05%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year154.92%
EBIT Next 3Y62.94%
EBIT Next 5YN/A
FCF growth 1Y192.14%
FCF growth 3YN/A
FCF growth 5Y-50.8%
OCF growth 1Y204.19%
OCF growth 3YN/A
OCF growth 5Y-45.06%